# Heritage Financial Corp: financial statements, quarterly

HFWA · Nasdaq · CIK 1046025 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hfwa.md) · [Financials](/companies/hfwa/financials.md) · [Filings](/companies/hfwa/filings.md) · [Insiders](/companies/hfwa/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hfwa/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [17.8](/filings/0001046025-23-000197.md) | [20.4 d](/filings/0001046025-24-000015.md) | [22.8](/filings/0001046025-24-000112.md) | [25.5](/filings/0001046025-24-000164.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [3.6](/filings/0001046025-24-000179.md) | [0.3 d](/filings/0001628280-26-012703.md) | [1.1](/filings/0001046025-25-000105.md) | [1.8](/filings/0001046025-25-000146.md) | [1.6](/filings/0001628280-25-050556.md) | [4.4 d](/filings/0001628280-26-012703.md) | [2.2](/filings/0001628280-26-032682.md) | [2.2](/filings/0001628280-26-054673.md) | [3.1](/filings/0001628280-25-050556.md) | [3.4 d](/filings/0001628280-26-012703.md) | [3.5](/filings/0001628280-26-032682.md) | [3.2](/filings/0001628280-26-054673.md) |
| Net income | $m | [18.2](/filings/0001046025-24-000179.md) | [6.2 d](/filings/0001628280-26-012703.md) | [5.7](/filings/0001046025-25-000105.md) | [14.2](/filings/0001046025-25-000146.md) | [11.4](/filings/0001628280-25-050556.md) | [11.9 d](/filings/0001628280-26-012703.md) | [13.9](/filings/0001628280-26-032682.md) | [12.2](/filings/0001628280-26-054673.md) | [19.2](/filings/0001628280-25-050556.md) | [22.2 d](/filings/0001628280-26-012703.md) | [18.9](/filings/0001628280-26-032682.md) | [17.5](/filings/0001628280-26-054673.md) |
| Diluted EPS | $ per share | [0.51](/filings/0001046025-24-000179.md) | not reported | [0.16](/filings/0001046025-25-000105.md) | [0.41](/filings/0001046025-25-000146.md) | [0.33](/filings/0001628280-25-050556.md) | not reported | [0.40](/filings/0001628280-26-032682.md) | [0.36](/filings/0001628280-26-054673.md) | [0.55](/filings/0001628280-25-050556.md) | not reported | [0.48](/filings/0001628280-26-032682.md) | [0.42](/filings/0001628280-26-054673.md) |
| Basic EPS | $ per share | [0.52](/filings/0001046025-24-000179.md) | not reported | [0.17](/filings/0001046025-25-000105.md) | [0.41](/filings/0001046025-25-000146.md) | [0.33](/filings/0001628280-25-050556.md) | not reported | [0.41](/filings/0001628280-26-032682.md) | [0.36](/filings/0001628280-26-054673.md) | [0.56](/filings/0001628280-25-050556.md) | not reported | [0.49](/filings/0001628280-26-032682.md) | [0.42](/filings/0001628280-26-054673.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [221](/filings/0001046025-23-000197.md) | [225](/filings/0001046025-25-000046.md) | [190](/filings/0001046025-24-000112.md) | [114](/filings/0001046025-24-000164.md) | [176](/filings/0001046025-24-000179.md) | [117](/filings/0001628280-26-012703.md) | [249](/filings/0001046025-25-000105.md) | [254](/filings/0001046025-25-000146.md) | [245](/filings/0001628280-25-050556.md) | [233](/filings/0001628280-26-054673.md) | [268](/filings/0001628280-26-032682.md) | [204](/filings/0001628280-26-054673.md) |
| Total assets | $m | [7,151](/filings/0001046025-23-000197.md) | [7,175](/filings/0001046025-25-000046.md) | [7,091](/filings/0001046025-24-000112.md) | [7,060](/filings/0001046025-24-000164.md) | [7,153](/filings/0001046025-24-000179.md) | [7,106](/filings/0001628280-26-012703.md) | [7,130](/filings/0001046025-25-000105.md) | [7,071](/filings/0001046025-25-000146.md) | [7,012](/filings/0001628280-25-050556.md) | [6,967](/filings/0001628280-26-054673.md) | [8,498](/filings/0001628280-26-032682.md) | [8,431](/filings/0001628280-26-054673.md) |
| Total liabilities | $m | [6,337](/filings/0001046025-23-000197.md) | [6,322](/filings/0001046025-25-000046.md) | [6,244](/filings/0001046025-24-000112.md) | [6,209](/filings/0001046025-24-000164.md) | [6,279](/filings/0001046025-24-000179.md) | [6,243](/filings/0001628280-26-012703.md) | [6,248](/filings/0001046025-25-000105.md) | [6,182](/filings/0001046025-25-000146.md) | [6,108](/filings/0001628280-25-050556.md) | [6,046](/filings/0001628280-26-054673.md) | [7,383](/filings/0001628280-26-032682.md) | [7,321](/filings/0001628280-26-054673.md) |
| Shareholders' equity | $m | [814](/filings/0001046025-24-000179.md) | [853](/filings/0001628280-26-012703.md) | [848](/filings/0001046025-25-000146.md) | [851](/filings/0001628280-25-050556.md) | [875](/filings/0001628280-25-050556.md) | [864](/filings/0001628280-26-054673.md) | [882](/filings/0001628280-26-054673.md) | [888](/filings/0001628280-26-054673.md) | [904](/filings/0001628280-25-050556.md) | [922](/filings/0001628280-26-054673.md) | [1,116](/filings/0001628280-26-054673.md) | [1,110](/filings/0001628280-26-054673.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [31.1 d](/filings/0001046025-24-000179.md) | [31.0 d](/filings/0001628280-26-012703.md) | [12.9](/filings/0001046025-25-000105.md) | [6.8 d](/filings/0001046025-25-000146.md) | [24.2 d](/filings/0001628280-25-050556.md) | [20.6 d](/filings/0001628280-26-012703.md) | [19.3](/filings/0001628280-26-032682.md) | [22.5 d](/filings/0001628280-26-054673.md) | [25.1 d](/filings/0001628280-25-050556.md) | [28.0 d](/filings/0001628280-26-012703.md) | [14.0](/filings/0001628280-26-032682.md) | [23.1 d](/filings/0001628280-26-054673.md) |
| Capital expenditure | $m | [3.8 d](/filings/0001046025-24-000179.md) | [1.1 d](/filings/0001628280-26-012703.md) | [0.9](/filings/0001046025-25-000105.md) | [0.8 d](/filings/0001046025-25-000146.md) | [0.9 d](/filings/0001628280-25-050556.md) | [0.8 d](/filings/0001628280-26-012703.md) | [1.2](/filings/0001628280-26-032682.md) | [1.6 d](/filings/0001628280-26-054673.md) | [0.7 d](/filings/0001628280-25-050556.md) | [5.7 d](/filings/0001628280-26-012703.md) | [1.3](/filings/0001628280-26-032682.md) | [2.0 d](/filings/0001628280-26-054673.md) |
| Dividends paid | $m | [7.7 d](/filings/0001046025-24-000179.md) | [7.7 d](/filings/0001628280-26-012703.md) | [8.0](/filings/0001046025-25-000105.md) | [8.0 d](/filings/0001046025-25-000146.md) | [7.9 d](/filings/0001628280-25-050556.md) | [7.9 d](/filings/0001628280-26-012703.md) | [8.2](/filings/0001628280-26-032682.md) | [8.2 d](/filings/0001628280-26-054673.md) | [8.1 d](/filings/0001628280-25-050556.md) | [8.2 d](/filings/0001628280-26-012703.md) | [8.2](/filings/0001628280-26-032682.md) | [9.9 d](/filings/0001628280-26-054673.md) |
| Share repurchases | $m | [2.6 d](/filings/0001046025-24-000179.md) | [0.0 d](/filings/0001628280-26-012703.md) | [6.1](/filings/0001046025-25-000105.md) | [4.4 d](/filings/0001046025-25-000146.md) | [7.5 d](/filings/0001628280-25-050556.md) | [4.4 d](/filings/0001628280-26-012703.md) | [0.8](/filings/0001628280-26-032682.md) | [4.6 d](/filings/0001628280-26-054673.md) | [0.0 d](/filings/0001628280-25-050556.md) | [0.0 d](/filings/0001628280-26-012703.md) | [1.0](/filings/0001628280-26-032682.md) | [10.1 d](/filings/0001628280-26-054673.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [35.5](/filings/0001046025-23-000197.md) | [35.4](/filings/0001046025-24-000112.md) | [35.1](/filings/0001046025-24-000164.md) | [35.1](/filings/0001046025-24-000179.md) | [35.2](/filings/0001046025-25-000105.md) | [34.9](/filings/0001046025-25-000146.md) | [34.7](/filings/0001628280-25-050556.md) | [34.5](/filings/0001628280-26-032682.md) | [34.4](/filings/0001628280-26-054673.md) | [34.4](/filings/0001628280-25-050556.md) | [39.1](/filings/0001628280-26-032682.md) | [41.5](/filings/0001628280-26-054673.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 40,915,558 at 2026-07-29, from the cover of the [10-Q filed 2026-08-07](/filings/0001628280-26-054673.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.